Clinical Trial

Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 10, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a multicenter, prospective, and observational clinical study aimed at exploring whether the 3-year DFS in the Huaier group is not inferior to the control group receiving standard platinum dual-drug chemotherapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-27; most recent amendment 2024-05-08.
Status change: Not Yet Recruiting → Recruiting 2024-05-08
Trial Details
NCT Number NCT06109454
Lead Sponsor Liaoning Cancer Hospital & Institute
Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions Non-small Cell Lung Cancer
Enrollment 240 participants
Start Date 2024-03-21
Primary Completion 2025-09 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2024-05-10